The "Infertility Panel NGS Genetic Test" is a comprehensive genetic screening designed to identify genetic factors that may contribute to infertility in individuals or couples struggling to conceive. Utilizing Next-Generation Sequencing (NGS) technology, this panel examines a wide array of genes known to be associated with various infertility issues, including but not limited to, hormonal imbalances, sperm production anomalies, and conditions affecting the reproductive system.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test offers a deep insight into the genetic underpinnings of infertility, enabling healthcare providers to tailor treatment strategies more effectively. By pinpointing specific genetic abnormalities, the test can guide decisions on fertility treatments, such as in vitro fertilization (IVF), and provide valuable information for genetic counseling.
The cost of the Infertility Panel NGS Genetic Test at DNA Labs UAE is 4400 AED. Given the intricate technology and the comprehensive analysis it provides, this test represents a significant step forward for couples seeking to understand the genetic factors affecting their fertility and exploring targeted interventions to achieve pregnancy.
The Blood Coagulation Panel NGS Genetic Test offered by DNA Labs UAE is a comprehensive genetic screening designed to identify mutations and genetic variants that may affect blood clotting processes. This test is particularly valuable for individuals with a personal or family history of blood clotting disorders, such as deep vein thrombosis, hemophilia, or thrombophilia, among others. By utilizing Next-Generation Sequencing (NGS) technology, this panel can accurately analyze multiple genes associated with coagulation pathways, providing insights into an individual's risk factors for developing coagulation disorders.
The cost of the Blood Coagulation Panel NGS Genetic Test is 4400 AED. This investment in health can be pivotal in guiding clinical decisions, including the management and treatment of coagulation disorders. Conducted in the state-of-the-art facilities of DNA Labs UAE, the test ensures high-quality, reliable results, allowing for personalized healthcare strategies based on one's genetic makeup. Whether for diagnostic, predictive, or preventive purposes, this genetic test serves as a critical tool in understanding and managing blood coagulation-related health issues.
The Genodermatoses Exome Sequencing Panel Test is a sophisticated genetic test designed to diagnose various inherited skin disorders known collectively as genodermatoses. This cutting-edge test examines the exome, which represents all the genes in the genome that encode proteins, to identify mutations that may lead to skin diseases. By focusing on the exonic regions of the genome, where most disease-causing mutations are found, this panel offers a comprehensive approach to understanding the genetic underpinnings of complex skin conditions.
Offered at DNA Labs UAE, a leading facility in genetic diagnostics, the test is priced at 4400 AED. The test aims to provide actionable insights for patients and healthcare providers, enabling a more personalized approach to treatment and management of genodermatoses. It is especially valuable for individuals with a family history of skin disorders or those exhibiting symptoms without a clear diagnosis. With its precise focus on skin-related genetic disorders, the Genodermatoses Exome Sequencing Panel Test represents a significant advancement in dermatological genetics and personalized medicine.
The "Next Generation Sequencing (NGS) Maturity Onset Diabetes of Young (MODY) Test" is a cutting-edge diagnostic procedure offered by DNA Labs UAE, designed to identify genetic mutations associated with MODY. This condition, a form of diabetes, typically manifests before the age of 25 and is characterized by a strong family history of diabetes, differing from the more common types 1 and 2 diabetes in its genetic origins and treatment strategies. Utilizing the advanced NGS technology, the test examines multiple genes simultaneously, ensuring a comprehensive analysis and a high degree of accuracy in identifying the specific genetic variations responsible for MODY.
Priced at 5500 AED, the test represents a significant advancement in the personalized diagnosis and management of diabetes, enabling targeted treatment plans and better outcomes for affected individuals. By pinpointing the exact genetic mutation, healthcare providers can tailor interventions more precisely, potentially improving the quality of life for those with MODY. DNA Labs UAE, by offering this sophisticated diagnostic tool, underscores its commitment to leveraging cutting-edge genomic technologies to enhance patient care.
The "Nx Gen Sequencing Tuberous Sclerosis Complex Test" is an advanced genetic test available at DNA Labs UAE, specifically designed to diagnose Tuberous Sclerosis Complex (TSC), a genetic disorder characterized by the growth of noncancerous (benign) tumors in many parts of the body. Priced at 4400 AED, this test utilizes Next Generation Sequencing (NGS) technology to accurately identify mutations in the TSC1 and TSC2 genes, which are known to cause the condition. By examining the patient's DNA, this test can confirm a diagnosis of TSC, helping in the early detection and management of the disease. The NGS technology ensures a high level of sensitivity and specificity, making it a valuable tool for healthcare providers and patients in managing Tuberous Sclerosis Complex.
The Cultured AFB Antitubercular DST Rapid 19 Drugs Panel Test is an advanced diagnostic procedure offered by DNA Labs UAE, designed to swiftly identify the drug susceptibility of Mycobacterium tuberculosis, the bacterium responsible for tuberculosis (TB). Priced at 5500 AED, this comprehensive test covers a panel of 19 drugs, providing critical information on the resistance patterns of the tuberculosis bacteria. This enables healthcare providers to tailor the most effective treatment plans for patients, significantly improving the chances of successful outcomes. The test involves culturing the bacteria from a patient's sample to evaluate how it responds to the various drugs, ensuring precise and targeted therapy in combating TB. By incorporating this test, DNA Labs UAE plays a pivotal role in the fight against tuberculosis, especially in cases where drug-resistant TB is a concern.
The "Ophthalmology Eyes Vision Panel NGS Genetic Test" is a comprehensive genetic screening tool designed to identify genetic mutations associated with various eye conditions and vision impairments. This test utilizes Next-Generation Sequencing (NGS) technology, a cutting-edge method that allows for the detailed analysis of multiple genes simultaneously, providing insights into the genetic basis of ophthalmic diseases. Conditions that can be detected through this panel include, but are not limited to, age-related macular degeneration, glaucoma, retinitis pigmentosa, and hereditary optic neuropathies.
Performed at DNA Labs UAE, a leading facility in genetic testing, this panel is priced at 5410 AED. DNA Labs UAE is known for its state-of-the-art technology and expertise in genetic diagnostics, offering accurate and reliable results. The test is a valuable resource for individuals with a family history of eye diseases, those experiencing symptoms of these conditions, or anyone interested in understanding their genetic predisposition to various eye and vision-related disorders. By identifying specific genetic mutations, the test can guide personalized treatment plans, preventive measures, and informed decision-making regarding eye health.
The Amyotrophic Lateral Sclerosis (ALS) Panel NGS Genetic Test, available at DNA Labs UAE for a cost of 4400 AED, is a comprehensive genetic screening designed to identify mutations associated with ALS, also known as Lou Gehrig's disease. This advanced test utilizes Next-Generation Sequencing (NGS) technology to analyze multiple genes simultaneously, providing a detailed insight into the genetic underpinnings of this progressive neurodegenerative disorder. ALS affects motor neurons in the brain and spinal cord, leading to muscle weakness, loss of motor control, and ultimately, paralysis. The test is crucial for individuals with a family history of ALS or those exhibiting symptoms, offering vital information for diagnosis, prognosis, and potential treatment options. By pinpointing specific genetic mutations, the ALS Panel NGS Genetic Test at DNA Labs UAE aids in understanding the risk and guiding decisions regarding management and therapeutic strategies.
The Ataxia Comprehensive Panel NGS Genetic Test is a cutting-edge diagnostic tool available at DNA Labs UAE, designed to identify genetic mutations associated with various forms of ataxia, a neurological disorder that affects coordination, balance, and speech. This test utilizes Next Generation Sequencing (NGS) technology, which allows for the simultaneous examination of multiple genes associated with ataxia, providing a comprehensive analysis of the patient's genetic makeup.
At a cost of 4400 AED, the test is an investment in pinpointing the specific genetic alterations that may be responsible for ataxic symptoms, facilitating a more tailored approach to treatment and management of the condition. By identifying the genetic underpinnings of ataxia, healthcare providers can offer patients more personalized care plans, potentially improving outcomes and quality of life.
DNA Labs UAE, where this test is conducted, is equipped with state-of-the-art technology and staffed by experts in the field of genetic testing, ensuring that patients receive accurate and reliable results. This test represents an important step forward in the field of neurogenetics and offers hope to individuals and families affected by ataxia, providing them with critical information that can guide their healthcare decisions.
The Ataxia Panel NGS (Next-Generation Sequencing) Genetic Test is a comprehensive diagnostic tool offered by DNA Labs UAE, designed to identify genetic mutations associated with various forms of ataxia. Ataxia is a neurological disorder characterized by a lack of muscle coordination which can affect speech, eye movements, and the ability to swallow, walk, and perform fine motor tasks. This condition can be caused by a wide range of genetic mutations, and the Ataxia Panel NGS Genetic Test targets these mutations to provide a precise diagnosis.
Utilizing cutting-edge NGS technology, this test examines multiple genes simultaneously, offering a thorough and efficient analysis. This approach not only increases the likelihood of identifying the specific genetic cause of ataxia in a patient but also reduces the need for multiple, separate genetic tests.
The test is priced at 4400 AED and is conducted at DNA Labs UAE, a facility known for its state-of-the-art genetic testing services. The cost reflects the comprehensive nature of the test and the advanced technology used. Once the test is completed, patients receive a detailed report that can guide their treatment plans and provide insight into the inheritance patterns of the disorder, which is crucial for family planning and understanding the risk to future generations.
